Literature DB >> 31727752

Quantification of Iodine Leakage on Dual-Energy CT as a Marker of Blood-Brain Barrier Permeability in Traumatic Hemorrhagic Contusions: Prediction of Surgical Intervention for Intracranial Pressure Management.

U K Bodanapally1, K Shanmuganathan2, Y P Gunjan3, G Schwartzbauer4, R Kondaveti5, T R Feiter2.   

Abstract

BACKGROUND AND
PURPOSE: Hemorrhagic contusions are associated with iodine leakage. We aimed to identify quantitative iodine-based dual-energy CT variables that correlate with the type of intracranial pressure management.
MATERIALS AND METHODS: Consecutive patients with contusions from May 2016 through January 2017 were retrospectively analyzed. Radiologists, blinded to the outcomes, evaluated CT variables from unenhanced admission and short-term follow-up head dual-energy CT scans obtained after contrast-enhanced whole-body CT. Treatment intensity of intracranial pressure was broadly divided into 2 groups: those managed medically and those managed surgically. Univariable analysis followed by logistic regression was used to develop a prediction model.
RESULTS: The study included 65 patients (50 men; median age, 48 years; Q1 to Q3, 25-65.5 years). Twenty-one patients were managed surgically (14 by CSF drainage, 7 by craniectomy). Iodine-based variables that correlated with surgical management were higher iodine concentration, pseudohematoma volume, iodine quantity in pseudohematoma, and iodine quantity in contusions. The regression model developed after inclusion of clinical variables identified 3 predictor variables: postresuscitation Glasgow Coma Scale (adjusted OR = 0.55; 95% CI, 0.38-0.79; P = .001), age (adjusted OR = 0.9; 95% CI, 0.85-0.97; P = .003), and pseudohematoma volume (adjusted OR = 2.05; 95% CI, 1.1-3.77; P = .02), which yielded an area under the curve of 0.96 in predicting surgical intracranial pressure management. The 2 predictors for craniectomy were age (adjusted OR = 0.89; 95% CI, 0.81-0.99; P = .03) and pseudohematoma volume (adjusted OR = 1.23; 95% CI, 1.03-1.45; P = .02), which yielded an area under the curve of 0.89.
CONCLUSIONS: Quantitative iodine-based parameters derived from follow-up dual-energy CT may predict the intensity of intracranial pressure management in patients with hemorrhagic contusions.
© 2019 by American Journal of Neuroradiology.

Entities:  

Year:  2019        PMID: 31727752      PMCID: PMC6975368          DOI: 10.3174/ajnr.A6316

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  27 in total

1.  Guidelines for the management of severe traumatic brain injury. VI. Indications for intracranial pressure monitoring.

Authors:  Susan L Bratton; Randall M Chestnut; Jamshid Ghajar; Flora F McConnell Hammond; Odette A Harris; Roger Hartl; Geoffrey T Manley; Andrew Nemecek; David W Newell; Guy Rosenthal; Joost Schouten; Lori Shutter; Shelly D Timmons; Jamie S Ullman; Walter Videtta; Jack E Wilberger; David W Wright
Journal:  J Neurotrauma       Date:  2007       Impact factor: 5.269

Review 2.  Review article: the surgical approach to the management of increased intracranial pressure after traumatic brain injury.

Authors:  Lucia M Li; Ivan Timofeev; Marek Czosnyka; Peter J A Hutchinson
Journal:  Anesth Analg       Date:  2010-08-04       Impact factor: 5.108

3.  Dual-Energy CT in Hemorrhagic Progression of Cerebral Contusion: Overestimation of Hematoma Volumes on Standard 120-kV Images and Rectification with Virtual High-Energy Monochromatic Images after Contrast-Enhanced Whole-Body Imaging.

Authors:  U K Bodanapally; K Shanmuganathan; G Issa; D Dreizin; G Li; K Sudini; T R Fleiter
Journal:  AJNR Am J Neuroradiol       Date:  2018-02-08       Impact factor: 3.825

4.  Early parenchymal contrast extravasation predicts subsequent hemorrhage progression, clinical deterioration, and need for surgery in patients with traumatic cerebral contusion.

Authors:  Abel Po-Hao Huang; Chung-Wei Lee; Hong-Jen Hsieh; Chi-Cheng Yang; Yi-Hsin Tsai; Fon-Yih Tsuang; Lu-Ting Kuo; Yuan-Shen Chen; Yong-Kwang Tu; Sheng-Jean Huang; Hon-Man Liu; Jui-Chang Tsai
Journal:  J Trauma       Date:  2011-12

5.  Imaging evidence and recommendations for traumatic brain injury: advanced neuro- and neurovascular imaging techniques.

Authors:  M Wintermark; P C Sanelli; Y Anzai; A J Tsiouris; C T Whitlow
Journal:  AJNR Am J Neuroradiol       Date:  2014-11-25       Impact factor: 3.825

6.  Computed tomography and outcome in moderate and severe traumatic brain injury: hematoma volume and midline shift revisited.

Authors:  Bram Jacobs; Tjemme Beems; Ton M van der Vliet; Ramon R Diaz-Arrastia; George F Borm; Pieter E Vos
Journal:  J Neurotrauma       Date:  2011-02-05       Impact factor: 5.269

Review 7.  Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury.

Authors:  Dan Shlosberg; Mony Benifla; Daniela Kaufer; Alon Friedman
Journal:  Nat Rev Neurol       Date:  2010-06-15       Impact factor: 42.937

8.  Contusion Contrast Extravasation Depicted on Multidetector Computed Tomography Angiography Predicts Growth and Mortality in Traumatic Brain Contusion.

Authors:  Marcos Rosa; Antônio José da Rocha; Antônio Carlos Martins Maia; Nelson Saade; José Carlos Esteves Veiga; Javier M Romero
Journal:  J Neurotrauma       Date:  2015-10-08       Impact factor: 5.269

9.  Effect of whole-body CT during trauma resuscitation on survival: a retrospective, multicentre study.

Authors:  Stefan Huber-Wagner; Rolf Lefering; Lars-Mikael Qvick; Markus Körner; Michael V Kay; Klaus-Jürgen Pfeifer; Maximilian Reiser; Wolf Mutschler; Karl-Georg Kanz
Journal:  Lancet       Date:  2009-03-25       Impact factor: 79.321

10.  Predictive Value of Leakage Signs for Pure Brain Contusional Hematoma Expansion.

Authors:  Kimihiko Orito; Masaru Hirohata; Yukihiko Nakamura; Masafumi Yamamoto; Nobuyuki Takeshige; Takachika Aoki; Gohsuke Hattori; Kiyohiko Sakata; Yasuharu Takeuchi; Hideaki Uzu; Osamu Takasu; Toshi Abe; Yusuke Uchiyama; Motohiro Morioka
Journal:  J Neurotrauma       Date:  2018-03-01       Impact factor: 5.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.